News
Generalversammlung der Ascom beschliesst erhöhte Dividendenausschüttung von CHF 0,30
Ad hoc Mitteilung gemäss Art. 53 KRBaar, Schweiz, 16. April 2024
Die Aktionäre der Ascom Holding AG haben an der ordentlichen Generalversammlung vom 16. April 2024 in Zug allen Anträgen
WilsonHCG in der RPO Baker's Dozen List 2023 von HRO Today zur Nr. 1 der globalen RPO-Anbieter ernannt
TAMPA, Florida, Sept. 21, 2023 (GLOBE NEWSWIRE) -- WilsonHCG ist in der Baker's Dozen List 2023 von HRO Today als Nr. 1 der Anbieter für Recruitment Process Outsourcing (RPO) anerkannt worden.
Artios and Merck KGaA announce global strategic collaboration
Artios and Merck KGaA announce global strategic collaboration
Arix to Present at the Jefferies Virtual London Healthcare Conference
Arix to Present at the Jefferies Virtual London Healthcare Conference
Hardman & Co Research: Arix Bioscience (ARIX): Hitting the jackpot
Hardman & Co Research: Arix Bioscience (ARIX): Hitting the jackpot
Arix Bioscience PLC: VelosBio to be acquired by Merck for $2.75 billion
Arix Bioscience PLC: VelosBio to be acquired by Merck for $2.75 billion
Hardman & Co Research: Arix Bioscience (ARIX): Realising the valuation disconnect
Hardman & Co Research: Arix Bioscience (ARIX): Realising the valuation disconnect
Arix Bioscience PLC: Autolus presents additional AUTO3 data in DLBCL
Arix Bioscience PLC: Autolus presents additional AUTO3 data in DLBCL
Arix Bioscience PLC: Interim Results for the Six Months Ended 30 June 2020
Arix Bioscience PLC: Interim Results for the Six Months Ended 30 June 2020
Hardman & Co Research: Arix Bioscience (ARIX): 1Q'20 portfolio update
Hardman & Co Research: Arix Bioscience (ARIX): 1Q'20 portfolio update
Hardman & Co Research: Arix Bioscience (ARIX): Resetting the stage
Hardman & Co Research: Arix Bioscience (ARIX): Resetting the stage
Hardman & Co Research: Arix Bioscience (ARIX): Fiscal 2019 - moving with the times
Hardman & Co Research: Arix Bioscience (ARIX): Fiscal 2019 - moving with the times
Hardman & Co Research: Q&A with Q&A with Dr Dorothea Hill on Arix Bioscience (ARIX)
Hardman & Co Research: Q&A with Q&A with Dr Dorothea Hill on Arix Bioscience (ARIX)
Hardman & Co Research: Arix Bioscience (ARIX) - Initiation of coverage: With high risk can come high reward
Hardman & Co Research: Arix Bioscience (ARIX) - Initiation of coverage: With high risk can come high reward
Update on the Scheme and Publication of Notice of Second General Meeting
Update on the Scheme and Publication of Notice of Second General Meeting
Financial update on Harpoon Therapeutics acquisition by Merck (MSD)
Financial update on Harpoon Therapeutics acquisition by Merck (MSD)